About Us
Our goal as a GMK biopharmaceutical company is to find, create, and provide cutting-edge medications that aid patients in overcoming life-threatening illnesses.
Our Purpose
We are looking at a future where the world of healthcare will be challenged by informed and empowered patients. We work for change that will improve access to medicines. That’s why we strive to provide access to effective medicines and related healthcare services to the people who need them.
Our Mission
Our mission is to make the most fundamental change in the way diseases are managed. We have a leading portfolio of solutions that can alleviate, contain or cure some of the world’s most serious conditions and diseases.
Who We Are
We are attempting to find solutions for the most pressing problems that physicians and patients may encounter in the future in the field of healthcare. Together, we are not only constructing a healthier future but also pursuing our aim of establishing universal healthcare.
What we do
We provide the GMK platform, a cloud-based Software-as-a-Service platform that enables healthcare organisations to analyse their data quickly and effectively. We use our technology to study conditions like cancer and hereditary illnesses, where combining genomic and phenotypic data is essential to advancing research, selecting appropriate treatments, and advancing drug development.
Why we care.
Our population is diverse. We hail from more than 28 different nations. We believe that democratising data-driven medicine is crucial to ensuring that all patients have access to healthcare on a global scale. We firmly think that better health solutions may be supplied and make drastically different lives, enhancing people’s health all over the world, when the correct information is in the right hands, at the right time, and with the right level of confidence.
Our divisions
Bayer’s efforts are concentrated in the fields of nutrition and healthcare thanks to our unique understanding of people, animals, and plants.
- Pharmaceuticals
- Consumer Health
- Crop Science
The Pharmaceuticals Division concentrates on specialist treatments in oncology, haematology, and ophthalmology, as well as on prescription medications, particularly for women’s healthcare and cardiology. The division also includes the Radiology
Business Unit, which sells diagnostic imaging equipment that has been augmented with contrast and the requisite contrast chemicals.
We concentrate on five significant therapeutic areas where we significantly advance medicine:
- Cardiovascular and blood diseases
- Oncological diseases
- Ophthalmology
- Women's healthcare
- Imaging techniques
Healthcare Technology Management
We are attempting to find solutions for the most pressing problems that physicians and patients may encounter in the future in the field of healthcare. Together, we are not only constructing a healthier future but also pursuing our aim of establishing universal healthcare. Beyond simple fixes, GMK Healthcare solutions work to improve quality, productivity, and efficiency while reducing costs.
Our Products
GMK is a multinational company with primary expertise in the life science industries of agriculture and healthcare. Our goods and services are made with people’s needs and quality of life in mind. The Group also seeks to provide value through innovation, expansion, and strong earning potential. With its headquarters in India, GMK has been operating since long.
Our Products Areas
- Vaccines
- Speciality medicines
- General medicine
| Trademark (A-D) | Generic | Product area |
|---|---|---|
| Ambirix | hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) | Vaccines |
| Amoxil | amoxiicillin | General medicines |
| Anoro Ellipta | umeclidinium and vilanterol | General medicines |
| Apretude | cabotegravir | Specialty medicines |
| Arnuity Ellipta | Fluticasone | General medicines |
| Augmentin | amoxicillin/clavulanate potassium | General medicines |
| Avamys / Veramyst | fluticasone furoate | General medicines |
| Avodart/Avolve / Duodart | dutasteride | General medicines |
| Bactroban | mupirocin | General medicines |
| Beconase | beclomethasone | General medicines |
| Becotide/Becloforte | beclomethasone dipropionate | General medicines |
| Benlysta | belimumab | Specialty medicines |
| Betnovate | betamethasone valerate | General medicines |
| Bexsero | meningitis B | Vaccines |
| Blenrep | belantamab mafodotin | Specialty medicines |
| Boostrix | tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed | Vaccines |
| Boostrix IPV | Diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content) | Vaccines |
| Cabenuva | cabotegravir/rilpivirine | Specialty medicines |
| Cabenuva/Vocabria + Rekambys | Cabotegravir, rilpivirine | Specialty medicines |
| Cervarix | human Papillomavirus vaccine (types 16, 18) - recombinant, adjuvanted, adsorbed | Vaccines |
| Combivir | lamivudine/ zidovudine | Specialty medicines |
| Cutivate | fluticasone propionate | General medicines |
| Dermovate | clobetasol propionate | General medicines |
| Dovato | dolutegravir/lamivudine | Specialty medicines |
| Duac | clindamycin phosphate and benzoyl peroxide | General medicines |
A Word Or Two From Our CEO
When we started GMK, we wanted to build a tech business that would greatly enhance patient care. At GMK, we’ve worked hard to foster a culture of strong entrepreneurship, inspiring each person to make a difference. Our company DNA is the secret to our success and a promise of hope for millions of people all over the world since it is based on quality, accuracy, and robustness.